Published : 11 September, 2024
In an industry article published in ET HealthWorld , Mr. D. S. Negi, CEO, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), along with Dr. Vineet Talwar, Director, Department of Medical Oncology, RGCIRC shared their views on the central government’s recent announcement of reduction in GST rates from 12% to 5% on cancer drugs following 54th GST Council meeting. They emphasised on how GST reduction on lifesaving drugs will help in making cancer treatment affordable.
As a society, RGCIRC is looking forward to get support from generous people
Read MoreIt is a fact that there are absolutely no substitutes to replace human bloo...
Read MoreVolunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays